GlassScriptPhysician profile
Jessica C Copland
NPI 1083743546
$1,332.45
in general payments reported to CMS, 2019-2025
22 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $103 · 2021: $71.70 · 2022: $84.39 · 2023: $298 · 2024: $231 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $296.11 | 2023-2025 | Freestyle Libre 3, Eterna, Freestyle Libre 2 |
| Novo Nordisk INC | $220.46 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $133.81 | 2019-2021 | |
| Abbvie INC. | $92.70 | 2022-2025 | Qulipta, Ubrelvy |
| Lilly USA, LLC | $86.31 | 2019-2023 | Mounjaro |
| Dexcom, INC. | $63.94 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $53.42 | 2023-2024 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $53.35 | 2019-2023 | Lokelma |
| Pfizer INC. | $49.08 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $34.30 | 2024 | Eliquis |
| Merck Sharp & Dohme LLC | $26.69 | 2019 | |
| Astellas Pharma US INC | $26.29 | 2023 | Veozah |
| Amarin Pharma, INC. | $24.37 | 2019 | |
| Daiichi Sankyo INC. | $23.62 | 2023 | Injectafer |
| Janssen Pharmaceuticals, INC | $23.42 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $23.29 | 2019 | |
| Organon LLC | $21.36 | 2023 | Nexplanon |
| Genentech USA, INC. | $19.51 | 2020 | |
| Exact Sciences Corporation | $16.36 | 2023 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $16.05 | 2020 | |
| Idorsia Pharmaceuticals US INC | $15.12 | 2022 | |
| Glaxosmithkline, LLC. | $12.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Copland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.